Skip to main content
OpenTrials
Completed

NCT Number: NCT01729962

Comparative Study of the Optical Biometer for Measurements of the Eye

The primary purpose of this comparative clinical study is to collect clinical data to demonstrate the equivalence of the investigational device to the predicate device for measurements of the eye. The secondary purpose is to evaluate any adverse events that occur during the clinical study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Physicians Protocol

Greensboro, North Carolina, 27410-2548, United States

About this study

This is a prospective clinical study to be conducted at a single clinical site located in the United States. This study will assess the agreement of an investigational device to the predicate device and an ultrasound reference device and the precision of the investigational device with a comparison to the precision of the predicate. Any adverse events associated with the investigational device can or the predicate device will be assessed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who can follow the instructions by the Principal/Clinical Investigator or clinical staff at the clinical site, and can visit on scheduled examination dates.
  • Subjects who sign an informed consent form to participate in the clinical trial.
  • Subjects who agree to take the qualifying eye examination and a series of devices measurements.
  • Subjects able to fixate on a target.
  • Subjects must meet at lease one of the following criteria:
  • Normal eyes: Subjects with a natural lens without a cataract, corneal abnormalities or prior keratorefractive surgery.
  • Eyes with Cataracts: Subjects with a pre-existing cataract without corneal abnormalities or prior keratorefractive surgery.
  • Eyes without a Natural Lens: Subjects that are pseudophakic or aphakic without corneal abnormalities or prior keratorefractive surgery.
  • Eyes with Corneal Abnormality: Subjects with a corneal abnormality and a natural lens without a cataract, or Subjects post keratorefractive surgery and a natural lens without a cataract.

Exclusion criteria

  • Pregnancy.
  • Any eye condition preventing use of any of the instruments used in the study.
  • Any eye condition which might impair the validity of results from any of the instruments used in the study.
  • Any medical condition, which, in the Investigator's judgment, interferes with the subject's ability to comply with the protocol, compromises subject safety, or interferes with the interpretation of the study results.

Treatment and study plan

Primary outcomes

  1. Agreement and Precision Endpoints Analyses

    Time frame: Subjects will be followed for the duration of the procedure, up to one day.

    The agreement of the Nidek optical biometer with the predicate device will be assessed for the following measures:

    • Axial Length;
    • Keratometry;
    • Corneal Cylinder Axis;
    • Anterior Chamber Depth;
    • Central Corneal Thickness;
    • White-to-White Distance; and
    • Pupil Diameter.

    In addition, the agreement of the Nidek optical biometer with the ultrasound reference device will be assessed for axial length and anterior chamber depth.

    The precision of Nidek optical biometer and the predicate device will be assessed for the following measures:

    • Axial Length;
    • Keratometry;
    • Corneal Cylinder Axis;
    • Anterior Chamber Depth;
    • Central Corneal Thickness;
    • White-to-White Distance; and
    • Pupil Diameter.

Secondary outcomes

  1. Evaluation of Adverse Events Found During the Study

    Time frame: Subjects will be followed for the duration of the procedure, up to one day.

    The safety endpoint is to evaluate any adverse events associated with the Nidek optical biometer or the predicate or reference devices.

Other outcomes

  1. Additional Analyses for the Agreement Portion of the Study

    Time frame: Subjects will be followed for the duration of the procedure, up to one day.

    Additional analyses will examine the intraocular lens (IOL) power calculation from the Nidek optical biometer only based on the subjects enrolled in the agreement portion of the study.

Sponsors and collaborators

Lead sponsor

Nidek Co. LTD.

Industry

Registry information

Official study title

Comparative Study of the Optical Biometer for the Measurements of Axial Length, Anterior Chamber Depth, Keratometry, Corneal Cylinder Axis, Corneal Thickness, White-to-White Distance, and Pupil Diameter

Important dates

Study start
2012
Primary completion
2013
Study completion
2013
First posted
Nov 21, 2012
Registry last updated
Jun 28, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.